HYBRID EVENT: You can participate in person at London, UK or Virtually from your home or work.

12th Edition of International Conference on Dentistry
and Oral Health

September 28-30 | London, UK

September 28-30, 2026 | London, UK

Cleidocranial Dysostosis

Cleidocranial Dysostosis

Cleidocranial dysostosis is an uncommon genetic disorder characterized by anomalies in bone development, particularly impacting the collarbones and skull. This condition results from mutations in the RUNX2 gene, disrupting proper bone formation and ossification. Individuals with cleidocranial dysostosis often present with distinctive physical traits, including the absence or underdevelopment of collarbones, delayed closure of fontanelles (soft spots) in the skull, and dental irregularities such as delayed eruption of adult teeth and the presence of extra teeth.

Beyond affecting the skeletal system, cleidocranial dysostosis influences facial structure and dental health. Challenges in speech and motor development may arise, accompanied by difficulties in fine and gross motor skills. The management of cleidocranial dysostosis necessitates a multidisciplinary approach, integrating orthopedic care, dental interventions, and speech therapy. Timely monitoring and early interventions are critical to addressing the specific challenges associated with this genetic disorder.

Despite the intricacies of cleidocranial dysostosis, ongoing advancements in medical knowledge and treatment options contribute to enhanced outcomes. Support groups and patient advocacy efforts play a pivotal role in providing valuable information and fostering a supportive community for individuals and families affected by this genetic condition. In essence, cleidocranial dysostosis highlights the intricate relationship between genetics and bone development, emphasizing the need for holistic care to address its diverse manifestations and improve the overall well-being of individuals grappling with this condition.

Tags

Submit your abstract Today

Watsapp